361 related articles for article (PubMed ID: 30070357)
1. Actinic keratosis - review for clinical practice.
de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR
Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Herms F
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS22-IIS30. PubMed ID: 31133226
[TBL] [Abstract][Full Text] [Related]
3. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
[TBL] [Abstract][Full Text] [Related]
4. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
5. Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Gupta AK; Paquet M
Br J Dermatol; 2013 Aug; 169(2):250-9. PubMed ID: 23550994
[TBL] [Abstract][Full Text] [Related]
6. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of actinic keratosis].
Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
[TBL] [Abstract][Full Text] [Related]
8. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
9. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
10. Contemporary management of actinic keratosis.
Navarrete-Dechent C; Marghoob AA; Marchetti MA
J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
[TBL] [Abstract][Full Text] [Related]
11. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
12. Addressing the Challenges of Treating Actinic Keratosis.
Kircik LH
J Drugs Dermatol; 2019 May; 18(5):s160. PubMed ID: 31141861
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of actinic keratosis.
Berman B; Amini S; Valins W; Block S
Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
[TBL] [Abstract][Full Text] [Related]
14. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
15. Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review.
Jetter N; Chandan N; Wang S; Tsoukas M
Am J Clin Dermatol; 2018 Aug; 19(4):543-557. PubMed ID: 29582369
[TBL] [Abstract][Full Text] [Related]
16. Conventional treatment of actinic keratosis: an overview.
Peris K; Fargnoli MC
Curr Probl Dermatol; 2015; 46():108-14. PubMed ID: 25561214
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Paugam C; Dréno B
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS31-IIS35. PubMed ID: 31133228
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
19. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
Gold MH
J Drugs Dermatol; 2008 Jan; 7(1):23-5. PubMed ID: 18246694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]